Case Report: Atypical Cutaneous Presentation of Human T-cell Lymphotropic Virus Type 1-Related Adult T-cell Lymphoma.
Adult
Antineoplastic Combined Chemotherapy Protocols
/ therapeutic use
Antiviral Agents
/ therapeutic use
Human T-lymphotropic virus 1
Humans
Interferon alpha-2
/ therapeutic use
Italy
Leukemia-Lymphoma, Adult T-Cell
/ diagnosis
Male
Nigeria
/ ethnology
Skin Neoplasms
/ diagnosis
Zidovudine
/ therapeutic use
Journal
The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507
Informations de publication
Date de publication:
11 10 2021
11 10 2021
Historique:
received:
06
06
2021
accepted:
04
08
2021
pubmed:
12
10
2021
medline:
22
2
2022
entrez:
11
10
2021
Statut:
epublish
Résumé
Human T-cell lymphotropic virus type 1 (HTLV-1) is a retrovirus endemic in many parts of the world. Because of migration, cases of HTLV-1 in non-HTLV-1 endemic countries have been increasingly reported. Clinical presentation of HTLV-1 infection is highly variable, with a significant risk of diagnostic delays. Skin can be the first site affected by HTLV-1-related manifestations such as cutaneous involvement of adult T-cell leukemia/lymphoma (ATLL) and infective dermatitis associated with HTLV-1. A 32-year-old Nigerian man was admitted to the infectious disease department for high fever, asthenia, lymphocytosis, and vesicular bullous lesions on both hand palms and lower limbs. After clinical work-up was performed, bacterial superinfected herpes simplex viurs-2 ulcers were the presenting sign of HTLV-1-related chronic type ATLL. Standard treatment based on interferon-α plus zidovudine was started, but it was poorly tolerated; therefore, switching to an off-label dual antiretroviral regimen was attempted. The increasing prevalence of HTLV-1 in nonendemic areas may enhance the development of alternative treatments with better efficacy and tolerability profiles.
Identifiants
pubmed: 34634767
doi: 10.4269/ajtmh.21-0630
pii: tpmd210630
pmc: PMC8641320
doi:
pii:
Substances chimiques
Antiviral Agents
0
Interferon alpha-2
0
Zidovudine
4B9XT59T7S
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM